| |
| | Bernard Fraisse Group to acquire Novartis production site in Hettlingen (CH) (Site not responding. Last check: 2007-10-15) |
 | | Novartis announced today the sale of its pharmaceutical production site in Hettlingen, Switzerland, to Bernard Fraisse Group effective October 1, 2004. |
 | | After reviewing our long-term strategy, we concluded that the Hettlingen facility will better prosper within a group that plans to develop the site in a new direction to optimize its long-term potential, said Andreas Rummelt, Head of Global Technical Operations, Novartis Pharma AG. |
 | | Products manufactured at this site include gels, ointments and drops such as Voltaren, Dispatim, Viscotears, Genteal and Ultracortenol. |
| www.prdomain.com /companies/n/novartis/news_releases/200409sep/pr_novartis_20040930.htm (288 words) |
|